TipRanks
Go Ultimate75% OFF

NuGen Medical Devices Inc (79O) Stock Statistics & Valuation Metrics

7 Followers

Total Valuation

NuGen Medical Devices Inc has a market cap or net worth of EUR 2.15M. The enterprise value is EUR 22.46M.

Market Cap
EUR 2.15M
Enterprise Value
EUR 22.46M

Share Statistics

NuGen Medical Devices Inc has 227,035,680 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
227,035,680
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

NuGen Medical Devices Inc’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

Return on Equity (ROE)
―
Return on Assets (ROA)
―
Return on Invested Capital (ROIC)
―
Return on Capital Employed (ROCE)
―
Revenue Per Employee
―
Profits Per Employee
-244.69K
Employee Count
15
Asset Turnover
―
Inventory Turnover
―

Income Statement

In the last 12 months, NuGen Medical Devices Inc had revenue of ― and earned -3.67M in profits. Earnings per share was ―.

Revenue
―
Gross Profit
34.38K
Operating Income
-2.61M
Pretax Income
―
Net Income
-3.67M
EBITDA
-2.59M
Earnings Per Share (EPS)
―

Stock Price Statistics

Beta
1.76
52-Week Price Change
-62.96%
50-Day Moving Average
0.01
200-Day Moving Average
0.01
Relative Strength Index (RSI)
42.14
Average Volume (3m)
75.00K

Important Dates

NuGen Medical Devices Inc upcoming earnings date is Dec 02, 2026, TBA (Not Confirmed).

Last Earnings Date
Aug 31, 2026
Next Earnings Date
Dec 02, 2026
Ex-Dividend Date
―

Balance Sheet

NuGen Medical Devices Inc has ― in cash and marketable securities with EUR 7.49M in debt, giving a net cash position of ― billion.

Cash & Marketable Securities
―
Total Debt
EUR 7.49M
Net Cash
―
Net Cash Per Share
―
Tangible Book Value Per Share
―

Analyst Forecast

The average price target for NuGen Medical Devices Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
0
Revenue Growth Forecast
-87.31%
EPS Growth Forecast
-177.89%